Skip to main content
ABVC BIOPHARMA, INC. logo

ABVC BIOPHARMA, INC. — Investor Relations & Filings

Ticker · ABVC ISIN · US00091F1066 US Manufacturing
Filings indexed 780 across all filing types
Latest filing 2009-05-08 Major Shareholding Noti…
Country US United States of America
Listing US ABVC

About ABVC BIOPHARMA, INC.

https://abvcpharma.com/

ABVC BioPharma, Inc. is a clinical-stage biopharmaceutical company that develops and commercializes drugs and medical devices to address unmet medical needs. The company focuses on advancing a pipeline of botanical, plant-based pharmaceuticals and medical technologies sourced from research institutions. Its therapeutic areas of focus include oncology, ophthalmology, and central nervous system disorders such as major depressive disorder (MDD) and adult attention-deficit/hyperactivity disorder (ADHD). Key products in development include Vitargus®, a biodegradable vitreous substitute for eye surgery, and botanical drug candidates for MDD and ADHD. Additionally, its subsidiary, BioKey, Inc., offers contract development and manufacturing services for nutritional and pharmaceutical products.

Recent filings

Filing Released Lang Actions
Major Shareholding Notification 2009
Major Shareholding Notification
2009-05-08 English
JB SMITH LC PROMISSORY NOTE 8-K
Regulatory Filings Classification · 95% confidence The document is a Form 8-K filed with the SEC, which is a current report used to announce major events that shareholders should know about. The content describes the issuance of a promissory note, a material definitive agreement, and includes details about the note's terms and related parties. It does not contain financial statements or detailed financial performance data. The document length is 3391 characters, which is relatively short and typical for an 8-K filing. This type of filing is best classified as a Regulatory Filing (RNS) because it is a general regulatory announcement about a material agreement and does not fit into more specific categories like Annual Report, Earnings Release, or Capital/Financing Update. Although it relates to a financing agreement, the 8-K form itself is a regulatory filing announcing the event rather than a detailed financing update report.
2009-05-05 English
Major Shareholding Notification 2009
Major Shareholding Notification
2009-05-05 English
FORM 4
Director's Dealing
2009-04-30 English
EQUITY 11 10TH TRANCHE
Capital/Financing Update Classification · 95% confidence The document is a Form 8-K Current Report filed with the SEC, dated April 30, 2009. It reports an unregistered sale of equity securities (Convertible Preferred Shares and warrants) to a purchaser, including details about the transaction and references to prior filings. The document is about a financing event and capital raising activity, specifically the sale of equity securities and issuance of warrants. It is not a full financial report, earnings release, or management discussion. The content fits the category of Capital/Financing Update (CAP) as it provides updates on company fundraising and capital structure changes. The document length is 4060 characters, which is typical for an 8-K filing of this nature and not a report publication announcement or regulatory filing fallback. Therefore, the best classification is CAP with high confidence.
2009-04-30 English
2ND QUARTER 2009 RESULTS PRESS RELEASE
Earnings Release Classification · 95% confidence The document is a Form 8-K current report filed with the SEC, dated April 28, 2009. It announces the company's financial results for the second quarter of fiscal year 2009 ending March 31, 2009. The text mentions a press release concerning the results and a financial results overview attached as exhibits. The document is relatively short (2769 characters) and primarily serves as an announcement of the quarterly financial results rather than containing detailed financial statements or substantive financial data itself. According to the rules, initial announcements of quarterly financial results with key highlights only are classified as Earnings Release (ER).
2009-04-28 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.